The fate of glyoxal and methylglyoxal in peritoneal dialysis.

[1]  A. Dawnay,et al.  Advanced Glycation End Product Free Adducts Are Cleared by Dialysis , 2005, Annals of the New York Academy of Sciences.

[2]  In‐San Kim,et al.  Effect of Glucose Degradation Products on the Peritoneal Membrane in a Chronic Inflammatory Infusion Model of Peritoneal Dialysis in the Rat , 2004, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[3]  V. Monnier,et al.  Advanced Maillard reaction products as markers for tissue damage in diabetes and uraemia: relevance to diabetic nephropathy , 1992, Acta Diabetologica.

[4]  A. Lapolla,et al.  An effective derivatization method for quantitative determination of glyoxal and methylglyoxal in plasma samples by gas chromatography/mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.

[5]  P. Traldi,et al.  Glyoxal and Methylglyoxal Levels in Diabetic Patients: Quantitative Determination by a New GC/MS Method , 2003, Clinical chemistry and laboratory medicine.

[6]  C. Wanner,et al.  Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? , 2003, Kidney international.

[7]  O. Devuyst,et al.  Chronic uremia induces permeability changes, increased nitric oxide synthase expression, and structural modifications in the peritoneum. , 2001, Journal of the American Society of Nephrology : JASN.

[8]  T. Miyata,et al.  Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids. , 2000, Kidney international.

[9]  T. Miyata,et al.  Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds. , 2000, Kidney international.

[10]  D. Choudhury,et al.  Advanced glycation end products: a Nephrologist's perspective. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  K. Shimokata,et al.  Gas chromatographic-mass spectrometric analysis of erythrocyte 3-deoxyglucosone in hemodialysis patients. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[12]  C. Schalkwijk,et al.  Induction of 1,2-Dicarbonyl Compounds, Intermediates in the Formation of Advanced Glycation End-Products, during Heat-Sterilization of Glucose-Based Peritoneal Dialysis Fluids , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[13]  K. Nitta,et al.  Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  T. Miyata,et al.  Carbonyl Stress: Increased Carbonyl Modification of Tissue and Cellular Proteins in Uremia , 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[15]  R. Krediet.  The peritoneal membrane in chronic peritoneal dialysis. , 1999, Kidney international.

[16]  T. Miyata,et al.  Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? , 1998, Kidney international.

[17]  R. Krediet.  Prevention and Treatment of Peritoneal Dialysis Mebrane Failure , 1998 .

[18]  T. Henle,et al.  3-Deoxyglucosone, a Promoter of Advanced Glycation end Products in Fluids for Peritoneal Dialysis , 1998, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[19]  C van Ypersele de Strihou,et al.  Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy. , 1997, Kidney international.

[20]  V. Monnier,et al.  Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis. , 1996, The Journal of clinical investigation.

[21]  A. Wieslander,et al.  In Vitro Biocompatibility of a Heat -Sterilized, Low Toxic, and Less Acidic Fluid for Peritoneal Dialysis , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[22]  V. Monnier,et al.  Pentosidine Formation in Skin Correlates With Severity of Complications in Individuals With Long-Standing IDDM , 1992, Diabetes.

[23]  V. Monnier,et al.  Chromatographic Quantitation of Plasma and Erythrocyte Pentosidine in Diabetic and Uremic Subjects , 1992, Diabetes.

[24]  V. Monnier,et al.  Nonenzymatic Glycosylation and Browning of Proteins In Vivo , 1983 .